Expression of p53, bcl-2 protein and Ki67 in basal cell tumours.
DOI:
https://doi.org/10.18004/Keywords:
Immunohistochemistry, basal cell carcinoma, p53, Bcl-2, Ki-67, ParaguayAbstract
Objective: To determine the expression of p53, bcl-2 and Ki-67 proteins, in diferent histological variants of basal cell carcinomas. Study design: Pilot study of immunohistochemical variables (p53, Bcl-2 and Ki-67) in 20 basal cell carcinomas, diagnosed and treated over a period of 9 months. Results: Immunostaining was positive in 35% of cases for p53 protein and in 70% for bcl-2 protein. Ki-67 protein expression varied between a minimum of 0% and a maximum of 60%. Conclusions: We could conclude that the rate of cell proliferation measured by Ki-67 antibody is negative in nodular forms and positive in non nodular, the expression of Bcl-2 protein is weakly positive in non nodular variants, and finally the expression of mutated p53 is seen in both groups, but is higher in not nodular forms. More studies would be necesary with more important number of patients and control group for these results been statistically significant.
References
1 Garcia R, Coltrera MB, Gown AM. Analysis of proliferative grade with anti PCNA7 cyclin monoclonal antibodies in fixed embedded tissues. Am J Pathol 1989; 134:733-9
2 Harris C, Hollstein M. Clinical implications of the p53 tumor supressor gene. N Eng J Med 1993; 329:1318-27
3 Harris C. Chemical and physical carcinogenesis: advances and perspectives for the 1990’s. Cancer Res 1991; 51:5023-44
4 Werness B, Levine A, Howley P. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Sciencie 1990; 248:76-9
5 Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53 associates protein in human sarcoma. Nature 1992; 358:80-3
6 Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C et al. Inmunobiochemical and molecular biologic characterization of cell proliferation-associated nuclear antigen. That is defined by monoclonal antibody Ki 67. Am J Pathol 1991; 138:867-73
7 García Montesinos B, Val Bernal JF, Saiz Bustillo R. Estudio inmunohistoquímico del carcinoma epidermoide de labio. Med Oral, Patol Oral y Cir Buc 2005; 10 (5)
8 Li Ma MD, Adam Ronai PD. Expression of p53 and Bcl-2 in squamous cell carcinoma of the Head and Neck: An inmunohistochemical study. Appl Inmunohistochemi 1998; 6:77-83
9 Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA et al. Tumor supressor P53 is a regulator of bcl-2 and box gene expression in vitro and in vivo. Oncogene 1994; 9:1799-1805
10 Tubiana M, Conroli A. Proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long term survival. Radiother Oncol 1989; 15:1-18
11 Lorz M, Meyer-Breiting E. Determination of cell proliferation using monoclonal antibodies studies of 21 squamous cell carcinoma of the head and neck area. Laryngol Rhinol Otol 1988; 67:539-42
